Showing 451-460 of 1780 results for "".
What to Know About Post-COVID-19 Neurological Syndrome
https://reachmd.com/programs/neurofrontiers/what-to-know-about-post-covid-19-neurological-syndrome/12876/Some patients who recover from COVID-19 may continue to experience neurological complications. So what are the symptoms we should be looking for?Evaluating Chronic Cough in Children
https://reachmd.com/programs/hot-topics-in-allergy/evaluating-chronic-cough-in-children/3914/Cough is one of the most common symptoms but can develop as a symptom of various disorders, from asthma to bacterial infection to gastroesophogeal reflux disorder. How important is the character of a cough in determining the cause in children particularly? Host Dr. Todd Mahr explores cough guidelineUsing Video to Repurpose Health Content: Easy Tools to Creating Video
https://reachmd.com/programs/healthcares-prescription-web-social-marketing/using-video-repurpose-health-content-easy-tools-creating-video/9651/Drs. Russ Faust and Randy Wong share a few of the trusted tools available to publish your first educational video.Ginkgo Biloba: How Supportive is the Data?
https://reachmd.com/programs/clinicians-roundtable/ginkgo-biloba-how-supportive-is-the-data/3203/Patients around the world looking for the Holy Grail in staving off cognitive impairment have been using ginkgo biloba for years, to the tune of $1 billion in annual sales worldwide. How strong is the data to support this use? Dr. Jeffrey Kaye, director of the National Institute on Aging's Layton AgIBD & Intimacy: Managing an Under-Recognized Issue
https://reachmd.com/programs/crohns-colitis-foundation-perspectives/ibd-and-intimacy-managing-an-under-recognized-issue/10081/Dr. Robert Frankel and Dr. Neilanjan Nandi discuss how to approach sexual and intimacy issues for IBD patients.Patient-Reported Outcomes From the Phase 3 KEYNOTE-689 Trial of Adding Perioperative Pembrolizumab to Standard of Care in Resectable Locally Advanced HNSCC
https://reachmd.com/clinical-practice/oncology-hematology/patient-reported-outcomes-from-the-phase-3-keynote-689-trial-of-adding-perioperative-pembrolizumab-to-standard-of-care-in-resectable-locally-advanced-hnscc/39777/In KEYNOTE-689, patient-reported outcomes including HRQOL remained stable vs baseline with perioperative pembrolizumab in resectable locally advanced HNSCC.Harnessing DED Data: Comparison Studies
https://reachmd.com/clinical-practice/optometry/harnessing-ded-data-comparison-studies/28667/Join Laura M. Periman, MD; Mile Brujic, OD, FAAO; and Jessica Steen, OD, FAAO, as they discuss dry eye disease. In this podcast, Dr. Steen discusses recent comparison studies. This content was captured during a live-virtual symposium. Polling took place during the symposium. This activity is suppoHow to Curb Patients’ Vaccine Hesitancy
https://reachmd.com/programs/vaccination/how-curb-patients-vaccine-hesitancy/10882/The value of vaccines is sadly masked by myths and controversies, but there are still ways we can counsel patients who want to skip the needle.Travel for IBD Patients: How to Help Them Prepare
https://reachmd.com/programs/crohns-colitis-foundation-perspectives/travel-for-ibd-patients-how-to-help-them-prepare/10082/Dr. Adam C. Ehrlich talks with Dr. Adam Kaufman regarding the importance of preparing your IBD patient for travel.Pharmacist Perspectives on the Challenging Type 2 Diabetic Patient in Primary Care
https://reachmd.com/programs/primary-care-today/pharmacist-perspectives-challenging-type-2-diabetic-patient-primary-care/7611/How can pharmacy practice inform the primary care and family medicine communities about approaching challenging diabetes cases? Christa George, Pharm.D, Associate Professor in the departments of Clinical Pharmacy and Family Medicine at the University of Tennessee Health Science Center, joins Dr. Bri